The use of synthetic ACTH (Synacthen) in patients with a history of asthma

19 Sept 2011

The Society for Endocrinology has issued a position statement that supports amendments that appear on the section on TETRACOSACTIDE (Tetracosactrin) (section 6.5.1) in the current issue of BNF62. Professor Ashley Grossman (University of Oxford) wrote the statement on behalf of the Society in the hope that it would be of help to endocrinologists in their practice.